JT Pharmaceuticals R&D Expenses
(Consolidated)
| Billions of yen | Millions of U.S. Dollars | |
| FY2023 | 32.2 | 228.62 (JPY 140.85 per US$) |
| FY2022 | 29.8 | 226.48 (JPY 131.58 per US$) |
| FY2021 | 29.0 | 263.88 (JPY 109.90 per US$) |
(Consolidated)
| Billions of yen | Millions of U.S. Dollars | |
| FY2023 | 32.2 | 228.62 (JPY 140.85 per US$) |
| FY2022 | 29.8 | 226.48 (JPY 131.58 per US$) |
| FY2021 | 29.0 | 263.88 (JPY 109.90 per US$) |